Nanotheranostics-based Management of Head and Neck Cancer

Nanotheranostics. 2023 Feb 5;7(2):202-209. doi: 10.7150/ntno.81724. eCollection 2023.


Head and neck cancer is affecting a large sort of population. Many treatments are available on a regular base, but they have their limitations. Diagnosis in the early stage is essential to cope with the disease which is a limitation in the majority of present diagnostic tools. Many of them are invasive methods that lead to patient discomfort. Interventional nanothernostics is an emerging field in the management of Head and Neck cancer. It facilitates both diagnostic and therapeutic approaches. It also helps with the overall management of the disease. This method allows the early and accurate detection of the disease which improvises the chances of recovery. Additionally, it makes sure that the medicine is delivered specifically to increase clinical outcomes and reduce side effects. The use of radiation in addition to the medicine supplied can produce a synergistic effect. It contains several nanoparticles, including silicon and gold nanoparticles. This review paper focuses on the shortcomings of existing therapeutic techniques and how nanotheranostics fills the void.

Keywords: Head and neck cancer; nanoparticles; nanotheranostics; treatment.

Publication types

  • Review

MeSH terms

  • Gold / therapeutic use
  • Head and Neck Neoplasms* / therapy
  • Humans
  • Metal Nanoparticles* / therapeutic use
  • Theranostic Nanomedicine


  • Gold